For Research Use Only. Not for use in diagnostic procedures.
Product Description
The kit is a qualitative in vitro nucleic acid amplification assay to detect and differentiate SARS-CoV-
2, influenza A virus (IFV A), and influenza B virus (IFV B) in oropharyngeal swab specimen from individuals
suspected of respiratory viral infection consistent with COVID-19, suspicious clustering cases and
those under investigation. This test uses a similar lab setting and procedure when compared to our
SARS-CoV-2 detection assay.
Features
Benefits
Specifications
– Applied Biosystems 7500 Fast Real-Time PCR System, Software v2.0.6
– Applied Biosystems 7500 Real-Time PCR System, Software v2.0.5
– Applied Biosystems QuantStudio 5 Real-Time PCR System, 96-Well, Software v1.5.1
– Bio-Rad CFX96 Touch Real-Time PCR Detection System, Software v3.1
– MGIEasy Nucleic Acid Extraction Kit, 96 or 1728 preps
– QIAamp Viral RNA Mini Kit, 50 or 250 preps
– MGISP-960RS Automated Sample Preparation System
– MGISP-100 Automated Sample Preparation System
Related Information
* Frequently Asked Questions (FAQ)
Contact Us
* Request a quote and your BGI representative will reply to you within 24 hours.